pNR-2/pS2 immunohistochemical staining in breast cancer: correlation with prognostic factors and endocrine response
- PMID: 1850611
- PMCID: PMC1972364
- DOI: 10.1038/bjc.1991.141
pNR-2/pS2 immunohistochemical staining in breast cancer: correlation with prognostic factors and endocrine response
Abstract
Expression of the oestrogen-regulated pNR-2/pS2 protein has been studied in paraffin sections of a series of 172 primary breast cancers using an immunohistochemical technique. Positive staining of tumour cells was found in 117 tumours (68%): most of these tumours contained only a small proportion of positive cells. pNR-2 immunohistochemical staining correlated positively and significantly with the presence of oestrogen receptor. Mean percentages of pNR-2 positive cells were lower in tumours from postmenopausal women. Smaller, better differentiated tumours were significantly more likely to stain positively for pNR-2. The percentages of pNR-2 positive tumour cells in primary tumours and synchronously excised lymph node metastases were very similar. pNR-2 expression showed an unexpected positive association with lymph node metastasis. We were unable to find any significant association between pNR-2 immunohistochemical staining and either time to relapse or overall survival. There was a significant association between pNR-2 expression in primary tumours and response to endocrine therapy on relapse: positive pNR-2 immunohistochemical staining in primary tumours is predictive of response to hormonal therapy on relapse.
Similar articles
-
Expression of the oestrogen regulated pNR-2 mRNA in human breast cancer: relation to oestrogen receptor mRNA levels and response to tamoxifen therapy.Br J Cancer. 1990 Jan;61(1):32-8. doi: 10.1038/bjc.1990.8. Br J Cancer. 1990. PMID: 2153395 Free PMC article.
-
Expression of the pNR-2/pS2 protein in diverse human epithelial tumours.Br J Cancer. 1991 Oct;64(4):677-82. doi: 10.1038/bjc.1991.380. Br J Cancer. 1991. PMID: 1911216 Free PMC article.
-
Expression of the pS2 peptide in primary breast carcinomas: comparison of membrane and cytoplasmic staining patterns.J Pathol. 1993 Oct;171(2):123-9. doi: 10.1002/path.1711710209. J Pathol. 1993. PMID: 8283349
-
Clinical significance of the estrogen regulated pS2 protein in mammary tumors.Crit Rev Oncol Hematol. 1993 Aug;15(1):13-21. doi: 10.1016/1040-8428(93)90017-x. Crit Rev Oncol Hematol. 1993. PMID: 8240704 Review.
-
Correlation between pS2 protein positivity, steroid receptor status and other prognostic factors in breast cancer.Int J Biol Markers. 1995 Apr-Jun;10(2):87-93. doi: 10.1177/172460089501000204. Int J Biol Markers. 1995. PMID: 7561244 Review.
Cited by
-
The human trefoil peptide, TFF1, is present in different molecular forms that are intimately associated with mucus in normal stomach.Gut. 2000 Mar;46(3):312-20. doi: 10.1136/gut.46.3.312. Gut. 2000. PMID: 10673290 Free PMC article.
-
pS2--a new cytosolic protein recognized by monoclonal antibodies as a marker of hormone sensitivity in breast cancer.Cell Biophys. 1993 Jan-Jun;22(1-3):101-10. doi: 10.1007/BF03033869. Cell Biophys. 1993. PMID: 7889536
-
Potential prognostic value in human breast cancer of cytosolic Nme1 protein detection using an original hen specific antibody.Br J Cancer. 1996 Mar;73(5):630-5. doi: 10.1038/bjc.1996.109. Br J Cancer. 1996. PMID: 8605098 Free PMC article.
-
Association of pS2 (TFF1) release with breast tumour proliferative rate: in vitro and in vivo studies.Cell Prolif. 1999 Apr-Jun;32(2-3):107-18. doi: 10.1046/j.1365-2184.1999.32230107.x. Cell Prolif. 1999. PMID: 10535357 Free PMC article.
-
pS2 is an independent factor of good prognosis in primary breast cancer.Br J Cancer. 1993 Jul;68(1):93-6. doi: 10.1038/bjc.1993.292. Br J Cancer. 1993. PMID: 8318427 Free PMC article.
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical